Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 11:22:100990.
doi: 10.1016/j.ajpc.2025.100990. eCollection 2025 Jun.

Disparities in statin use following identification of coronary artery calcium

Affiliations

Disparities in statin use following identification of coronary artery calcium

Charlotte C Ellberg et al. Am J Prev Cardiol. .

Abstract

Background: Coronary artery calcium (CAC) scoring is a useful tool for risk stratification in asymptomatic individuals, and current clinical practice is to utilize statins in individuals with CAC. A growing body of research has aimed to identify and mitigate health disparities and their relation to cardiovascular disease (CVD) risk. Likewise, studies have highlighted social determinants of health (SDOH) that contribute to health disparities in CVD.

Objectives: We aimed to evaluate whether disparities exist with regards to statin use after identification of CAC within the Multi-Ethnic Study of Atherosclerosis (MESA).

Methods: The associations between race/ethnicity, age, sex, primary language, and an aggregate SDOH score (calculated using previously defined methods) with statin use at short- and long-term follow-up were evaluated in logistic regression models with adjustment for traditional CVD risk factors in individuals with baseline CAC>0 without baseline statin use.

Results: In the overall cohort, 3416 participants had CAC = 0, 1794 CAC 1-99, 757 CAC 100-300, and 847 CAC>300 AU Mean age was 62 (10.2) years, 53 % (n = 3601) were women, 38.5 % (n = 2622) were non-Hispanic White, 27.8 % (n = 1892) were non-Hispanic Black, 22.0 % (n = 1892) were Hispanic and 11.8 % (n = 1892) were Chinese. At short-term follow up (median 1.6 years, n = 2665), those with a higher SDOH score (worse burden) (OR 0.39, 95 % CI 0.16-0.91), Hispanic (OR 0.59, 95 % CI 0.40-0.85) and Spanish speaking individuals (OR 0.51, 95 % CI 0.30-0.83) were less likely to report statin use following CAC identification. At long-term follow up (median 9.4 years, n = 2533), Black individuals (OR 0.71, 95 % CI 0.52-0.96), Chinese (OR 0.58, 95 % CI 0.39-0.86) and Chinese speaking individuals (OR 0.50, 95 % CI 0.33-0.76) were also less likely to report statin use following CAC identification, and a trend was noted for SDOH score (OR 0.53, 95 % CI 0.26-1.09).

Conclusions: This study identifies disparities in statin use by race/ethnicity, language, and social determinants of health after identification of CAC. While CAC is an effective tool for identifying atherosclerosis in asymptomatic individuals, more equitable use of subsequent therapy is needed.

Keywords: Coronary artery calcium; Disparities; Statin.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Harpreet S. Bhatia reports financial support was provided by National Institutes of Health. H.S.B - consultant / advisor for Kaneka, Novartis, Abbott, Arrowhead; editorial board for AJPC M.D.S - supported by institutional grants from Amgen, Arrowhead, Boehringer Ingelheim, 89Bio, Esperion, Novartis, Ionis, Merck, and New Amsterdam. He has participated in Scientific Advisory Boards with Amgen, Agepha, Ionis, Novartis, New Amsterdam, and Merck. He has served as a consultant for Ionis, Novartis, Regeneron, Aidoc, Shanghai Pharma Biotherapeutics, Kaneka, Novo Nordisk, Arrowhead, and Tourmaline. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Unlabelled image
Central Illustration.
Fig 1
Fig. 1
Components of the SDOH Aggregate Score.
Fig 2
Fig. 2
Flow diagram of participant exclusion criteria.
Fig 3
Fig. 3
Prevalence of statin use at follow-up by race/ethnicity, language, and social determinants of health. p < 0.001 for race/ethnicity and language at long-term follow-up.
Fig 4
Fig. 4
Social determinants of health and statin use at follow-up exams. Adjusted for traditional risk factors (age, sex, BMI, SBP, total cholesterol, HDL-C, diabetes mellitus, smoking status, use of anti-hypertensive medications). Abbreviations per Table 1.

Similar articles

References

    1. Simon S., Ho P.M. Ethnic and racial disparities in acute myocardial infarction. Curr Cardiol Rep. 2020;22(9) doi: 10.1007/s11886-020-01351-9. - DOI - PubMed
    1. Allison J.J., Kiefe C.I., Centor R.M., Box J.B., Farmer R.M. Racial differences in the medical treatment of elderly medicare patients with acute myocardial infarction. J Gen Intern Med. 1996;11:736–743. doi: 10.1007/BF02598987. - DOI - PubMed
    1. Frank D.A., Johnson A.E., Hausmann L.R.M., Gellad W.F., Roberts E.T., Vajravelu R.K. Disparities in guideline-recommended statin use for prevention of atherosclerotic cardiovascular disease by race, ethnicity, and gender A nationally representative cross-sectional analysis of adults in the United States. Ann Intern Med. 2023;176(8):1057–1066. doi: 10.7326/M23-0720. - DOI - PMC - PubMed
    1. Acquah I., Hagan K., Javed Z., et al. Social determinants of cardiovascular risk, subclinical cardiovascular disease, and cardiovascular events. J Am Heart Assoc. 2023;12(6) doi: 10.1161/JAHA.122.025581. - DOI - PMC - PubMed
    1. Zhao M., Woodward M., Vaartjes I., et al. Sex differences in cardiovascular medication prescription in primary care: a systematic review and meta-analysis. J Am Heart Assoc. 2020;9(11) doi: 10.1161/JAHA.119.014742. - DOI - PMC - PubMed

LinkOut - more resources